Literature DB >> 21234508

Low prevalence of middle ear disease in cystic fibrosis patients.

Luciana Martins1, Roberto E S Guimarães, Helena M G Becker, Maria Beatriz Bedran, Marcelo Medeiros, Paulo Camargos.   

Abstract

OBJECTIVE: To assess the prevalence of middle ear alterations in cystic fibrosis (CF) patients.
METHODS: In this descriptive study, 120 CF patients aged 5 months to 18 years were assessed by clinical history, otoscopy, and tympanometry. Data on P. aeruginosa colonization and parenteral and/or inhaled aminoglycoside use were also collected from medical charts.
RESULTS: Clinical history revealed absence of previous otitis media in 57% of patients. Tympanic membranes were normal in 94% of patients who underwent otoscopic evaluation; chronic otitis media was suggested in about 1% of the cases, otitis media with effusion (OME) in 2%, and Eustachian tube dysfunction in 3%. As for tympanometry, 91% of patients who underwent the exam showed normal results, OME was suggested in 2% of the cases, and Eustachian tube dysfunction in 7%.
CONCLUSION: There was a low prevalence rate of middle ear alterations in our series of CF patients. The use of aminoglycosides and colonization by P. aeruginosa did not influence the prevalence of middle ear alterations. Our results suggest that a detailed clinical history and a routine otoscopy evaluation may confirm or rule out most middle ear alterations in CF patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21234508     DOI: 10.2223/JPED.2061

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  5 in total

1.  Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.

Authors:  Angela C Garinis; Douglas H Keefe; Lisa L Hunter; Denis F Fitzpatrick; Daniel B Putterman; Garnett P McMillan; Jeffrey A Gold; M Patrick Feeney
Journal:  Ear Hear       Date:  2018 Jan/Feb       Impact factor: 3.570

Review 2.  Nasal Mucociliary Clearance in Adenoid Hypertrophy and Otitis Media with Effusion.

Authors:  Hasmet Yazıcı
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.806

3.  Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.

Authors:  Chelsea M Blankenship; Lisa L Hunter; M Patrick Feeney; Madison Cox; Lindsey Bittinger; Angela C Garinis; Li Lin; Gary McPhail; John P Clancy
Journal:  Am J Audiol       Date:  2021-01-19       Impact factor: 1.636

4.  The Audiometric Findings among Curitiba and Metropolitan Area Students.

Authors:  Regina Klas; Adriana Lacerda
Journal:  Int Arch Otorhinolaryngol       Date:  2014-02-10

5.  Otitis media prone children with cystic fibrosis: A new normal.

Authors:  Jennifer L McCoy; Thomas M Kaffenberger; Tiffany S Yang; Joseph E Dohar
Journal:  Am J Otolaryngol       Date:  2021-06-19       Impact factor: 2.873

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.